SynthesisJournal of evidence-based complementary & alternative medicine2017
Clinical Effects of Krachaidum ( Kaempferia parviflora): A Systematic Review.
Synthesis in Journal of evidence-based complementary & alternative medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 59 citations in OpenAlex.
- Skin Rejuvenation Efficacy and Safety Evaluation ofBiomolecules · 2024Trial
- Article
- Identification of a novel oral potential multiple agonist for obesity treatment: multi-target in silico study.Journal of computer-aided molecular design · 2026Article
- Article
- 8-WeekAntioxidants (Basel, Switzerland) · 2024Article
- The potential of traditional herbal active ingredients in the treatment of sarcopenia animal models: focus on therapeutic effects and mechanisms.Naunyn-Schmiedeberg's archives of pharmacology · 2023Review
- A Functional Drink ContainingFoods (Basel, Switzerland) · 2023Article
- Methoxyflavones from Black Ginger (Plants (Basel, Switzerland) · 2023Article
- Kaempferia parviflora rhizome extract exerts anti-obesity effect in high-fat diet-induced obese C57BL/6N mice.Food & nutrition research · 2023Article
- Antiobesity effect ofFood & nutrition research · 2023Article
- The industrially important genusFrontiers in pharmacology · 2023Review
- Black Ginger (Nutrients · 2022Article
- Article
- Improvement of Damage in Human Dermal Fibroblasts by 3,5,7-Trimethoxyflavone from Black Ginger (Antioxidants (Basel, Switzerland) · 2022Article
- Protective Effect of Polymethoxyflavones Isolated fromAntioxidants (Basel, Switzerland) · 2021Article
- Article
- The Potential Role of Circulating MicroRNAs in Male Rat Infertility Treated withEvidence-based complementary and alternative medicine : eCAM · 2021Article
- Herbal or traditional medicine consumption in a Thai worker population: pattern of use and therapeutic control in chronic diseases.BMC complementary and alternative medicine · 2019Article
- Effect of the active ingredient of Kaempferia parviflora, 5,7-dimethoxyflavone, on the pharmacokinetics of midazolam.Journal of natural medicines · 2018Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kaempferia parviflora (Krachaidum) is a medicinal plant in the family Zingiberaceae. Its rhizome has been used as folk medicine for many centuries. A number of pharmacological studies of Krachaidum had claimed benefits for various ailments. Therefore, this study aimed to systematically search and summarize the clinical evidences of Krachaidum in all identified indications. Of 683 records identified, 7 studies were included. From current clinical trials, Krachaidum showed positive benefits but remained inconclusive since small studies were included. Even though results found that Krachaidum significantly increased hand grip strength and enhanced sexual erotic stimuli, these were based on only 2 studies and 1 study, respectively. With regard to harmful effects, we found no adverse events reported even when Krachaidum 1.35 g/day was used. Therefore, future studies of Krachaidum are needed with regards to both safety and efficacy outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.